Exploration of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses

Roche R&D Center China, Shanghai, China.
Bioorganic & medicinal chemistry letters (Impact Factor: 2.42). 10/2010; 20(20):6020-3. DOI: 10.1016/j.bmcl.2010.08.068
Source: PubMed


Further investigation of the recently reported piperidine-4-yl-aminopyrimidine class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) has been carried out. Thus, preparation of a series of N-phenyl piperidine analogs resulted in the identification of 3-carboxamides as a particularly active series. Analogs such as 28 and 40 are very potent versus wild-type HIV-1 and a broad range of NNRTI-resistant mutant viruses. Synthesis, structure-activity relationship (SAR), clearance data, and crystallographic evidence for the binding motif are discussed.

Download full-text


Available from: Guozhi Tang, Oct 08, 2014
30 Reads
Show more